biological_process

GLYMPHATIC

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about GLYMPHATIC: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

64Connections

18Hypotheses

0Analyses

39Outgoing

25Incoming

17Experiments

0Debates

No summary available yet.

View on Wiki →

No AI portrait yet

🧬 Biological Process Info

Name	GLYMPHATIC

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

NPH Glymphatic System Interaction Experiment

experiment · 2418 words

→

Pathway Diagram

graph TD
    GLYMPHATIC["GLYMPHATIC"] -->|"accumulates in"| NEURODEGENERATION["NEURODEGENERATION"]
    style NEURODEGENERATION fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
    GLYMPHATIC["GLYMPHATIC"] -->|"associated"| MACROPHAGE["MACROPHAGE"]
    style MACROPHAGE fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
    GLYMPHATIC["GLYMPHATIC"] -->|"associated"| MACROPHAGES["MACROPHAGES"]
    style MACROPHAGES fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
    GLYMPHATIC["GLYMPHATIC"] -->|"expressed in"| STROKE["STROKE"]
    style STROKE fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
    GLYMPHATIC["GLYMPHATIC"] -->|"co discussed"| SLEEP["SLEEP"]
    style SLEEP fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
    GLYMPHATIC["GLYMPHATIC"] -->|"co discussed"| STING["STING"]
    style STING fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
    GLYMPHATIC["GLYMPHATIC"] -->|"co discussed"| TAU["TAU"]
    style TAU fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
    ALZHEIMER["ALZHEIMER"] -->|"accumulates in"| GLYMPHATIC["GLYMPHATIC"]
    style ALZHEIMER fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
    ALZHEIMER_S["ALZHEIMER'S"] -->|"accumulates in"| GLYMPHATIC["GLYMPHATIC"]
    style ALZHEIMER_S fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
    ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"] -->|"accumulates in"| GLYMPHATIC["GLYMPHATIC"]
    style ALZHEIMER_S_DISEASE fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
    AMYLOID["AMYLOID"] -->|"accumulates in"| GLYMPHATIC["GLYMPHATIC"]
    style AMYLOID fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
    AGING["AGING"] -->|"regulates"| GLYMPHATIC["GLYMPHATIC"]
    style AGING fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
    style GLYMPHATIC fill:#5d4400,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0,font-weight:bold

Outgoing (39)

Target	Relation	Type	Str
SLEEP	co_discussed	entity	0.50
STROKE	co_discussed	entity	0.50
STING	co_discussed	entity	0.50
TAU	co_discussed	entity	0.50
NEURODEGENERATION	co_discussed	entity	0.50
NEUROINFLAMMATION	co_discussed	entity	0.50
MULTIPLE SCLEROSIS	co_discussed	entity	0.50
PARKINSON	co_discussed	entity	0.50
PARKINSON'S	co_discussed	entity	0.50
NEURON	co_discussed	entity	0.50
SYNAPTIC PLASTICITY	co_discussed	entity	0.50
PERICYTE	co_discussed	entity	0.50
PERICYTES	co_discussed	entity	0.50
MACROPHAGE	co_discussed	entity	0.50
MACROPHAGES	co_discussed	entity	0.50
HIPPOCAMPUS	co_discussed	entity	0.50
SNCA	co_discussed	entity	0.50
INTERNEURON	co_discussed	entity	0.50
INTERNEURONS	co_discussed	entity	0.50
HUNTINGTON	co_discussed	entity	0.50
MYELINATION	co_discussed	entity	0.50
WHITE MATTER	co_discussed	entity	0.50
OXIDATIVE STRESS	co_discussed	entity	0.50
SYNAPSE	co_discussed	entity	0.50
LRRK2	co_discussed	entity	0.50
MITOCHONDRIA	co_discussed	entity	0.50
MITOCHONDRIAL DYSFUNCTION	co_discussed	entity	0.50
MS	co_discussed	entity	0.50
TBI	co_discussed	entity	0.50
NEURONS	co_discussed	entity	0.50
SCHIZOPHRENIA	co_discussed	entity	0.50
TAU PROPAGATION	co_discussed	entity	0.50
TDP-43	co_discussed	entity	0.50
MICROGLIA	co_discussed	entity	0.50
UNFOLDED PROTEIN RESPONSE	co_discussed	entity	0.50
PHAGOCYTOSIS	co_discussed	entity	0.50
PRION-LIKE	co_discussed	entity	0.50
LOCUS COERULEUS	co_discussed	entity	0.50
VEGF	co_discussed	entity	0.50

Incoming (25)

Source	Relation	Type	Str
ASTROCYTE	co_discussed	entity	0.50
ASTROCYTES	co_discussed	entity	0.50
EPILEPSY	co_discussed	entity	0.50
BLOOD-BRAIN BARRIER	co_discussed	entity	0.50
BBB	co_discussed	entity	0.50
COMPLEMENT	co_discussed	entity	0.50
CHOLINERGIC	co_discussed	entity	0.50
CIRCADIAN	co_discussed	entity	0.50
DEMENTIA	co_discussed	entity	0.50
CORTEX	co_discussed	entity	0.50
GFAP	co_discussed	entity	0.50
ENDOTHELIAL	co_discussed	entity	0.50
DOPAMINERGIC	co_discussed	entity	0.50
DEMYELINATION	co_discussed	entity	0.50
ANGIOGENESIS	co_discussed	entity	0.50
APP	co_discussed	entity	0.50
ALS	co_discussed	entity	0.50
GBA	co_discussed	entity	0.50
GABA	co_discussed	entity	0.50
GABAergic	co_discussed	entity	0.50
AUTOPHAGY	co_discussed	entity	0.50
DEPRESSION	co_discussed	entity	0.50
AQP4	co_discussed	entity	0.50
ALZHEIMER	co_discussed	entity	0.50
ALZHEIMER'S	co_discussed	entity	0.50

Targeting Hypotheses (18)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Cl	0.869	neuroscience	Circuit-level neural dynamics in neurode
Circadian Glymphatic Entrainment via Targeted Orexin Recepto	0.841	neurodegeneration	Perivascular spaces and glymphatic clear
Closed-loop transcranial focused ultrasound to restore hippo	0.827	Alzheimer's disease	Circuit-level neural dynamics in neurode
Glymphatic-Mediated Tau Clearance Dysfunction	0.821	neuroscience	Circuit-level neural dynamics in neurode
Sleep-Dependent Glymphatic Clearance Expands the Therapeutic	0.780	neurodegeneration	What is the therapeutic window between t

Circadian Glymphatic Rescue Therapy (Melatonin-focused)	0.712	neurodegeneration	Sleep disruption as cause and consequenc
Loss of AQP4 Polarization Impairs Glymphatic Perivascular In	0.690	neurodegeneration	What are the specific molecular mechanis
Glymphatic-Cholinergic Tau Clearance Cascade	0.666	neuroscience	Circuit-level neural dynamics in neurode
Treat Glymphatic Failure by Coupling AQP4-Targeted Therapy t	0.630	neurodegeneration	How can AQP4 be effectively targeted the
AQP4 Missorting in Reactive Astrocytes Drives Glymphatic Fai	0.580	neurodegeneration	What are the specific molecular mechanis
Closed-loop transcranial focused ultrasound to restore hippo	0.564	Alzheimer's disease	Circuit-level neural dynamics in neurode
Ketone-Primed Thalamocortical Enhancement of Glymphatic Tau	0.555	neuroscience	Circuit-level neural dynamics in neurode
TREM2-GluN2B Circuit: Microglial Control of Thalamocortical	0.543	neuroscience	Circuit-level neural dynamics in neurode
Glymphatic System-Enhanced Antibody Clearance Reversal	0.537	neurodegeneration	Blood-brain barrier transport mechanisms
TREM2-Dependent Microglial Control of Thalamocortical-Glymph	0.524	neuroscience	Circuit-level neural dynamics in neurode
Restoring AQP4 Astrocyte Polarization Enhances Glymphatic Ta	0.520	neurodegeneration	Investigate prion-like spreading of tau
Targeting AQP4 Sumoylation to Enhance Glymphatic Clearance a	0.490	neurodegeneration	What are the specific molecular mechanis
GluN2B-Mediated Perivascular Pericyte Control of Glymphatic	0.485	neuroscience	Circuit-level neural dynamics in neurode

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (17)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs AD with Co	clinical	Alzheimer's Disease	0.900	0.50	aortic endothelial cells	proposed	$6,550,000
Tau depletion effects on neuronal development in primary cultures	exploratory		0.900	0.00	primary rodent neuronal cultur	proposed	N/A
Differential GWAS of schizophrenia vs PTSD	exploratory	schizophrenia, post-traumatic	0.900	0.00	human patients - European ance	proposed	N/A
Tau depletion effects on neuronal development in primary cultures	exploratory		0.900	0.00	primary rodent neuronal cultur	proposed	N/A
Creation and validation of 3xAD-ChAT-Cre mouse model	validation	Alzheimer's disease	0.900	0.00	3xAD-ChAT-Cre transgenic mice	proposed	N/A
GTEx brain tissue expression analysis of MAPT/CRHR1 locus	exploratory	schizophrenia, post-traumatic	0.850	0.00	human brain tissue samples fro	proposed	N/A
Microtubule domain analysis in adult axons	exploratory		0.800	0.00	adult rodent axons	proposed	N/A
Tau depletion effects on microtubule domains in adult axons	exploratory		0.800	0.00	adult rodent neurons	proposed	N/A
s:** - Test tau spreading in AQP4 knockout vs wild-type mice with PSP/	falsification	Neurodegeneration	0.400	0.50	mouse	proposed	$260,000
Circadian-Vascular-Metabolic Syndrome (CVMS) Intervention Trial	clinical	Neurodegeneration	0.400	0.50	human	proposed	$3,900,000
DLB Cognitive Fluctuation Mechanism Experiment	clinical	Neurodegeneration	0.400	0.50	human	proposed	$6,550,000
Glymphatic-Circadian Axis Enhancement Therapy for Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$5,460,000
Non-Motor Symptom Progression in Parkinson's Disease — Mechanisms and	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$5,460,000
NPH Glymphatic System Interaction Experiment	clinical	Neurodegeneration	0.400	0.50	human	proposed	$5,460,000
Sleep and Circadian Dysfunction as Driver of Neurodegeneration	clinical	Neurodegeneration	0.400	0.50	human	proposed	$5,460,000
Sleep Disruption and Alzheimer's Disease — mechanism and intervention	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$5,460,000
Sleep and Respiratory Network Interaction in ALS — Experiment Design	clinical	ALS	0.400	0.50	human	proposed	$5,460,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Combined effects of HCRTR1/2 gene variants and non-genetic factors on sleep-wake [PMID:40439868]	Zheng Z, Xue F, Wang H, Gu Q, Hu R, Li X	Pharmacol Rep	2025	1
Genetic determinants of daytime napping and effects on cardiometabolic health. [PMID:33568662]	Dashti HS, Daghlas I, Lane JM, Huang Y,	Nat Commun	2021	1
Prevalence of symptoms of depression, anxiety, insomnia, posttraumatic stress di [PMID:33285346]	Cénat JM, Blais-Rochette C, Kokou-Kpolou	Psychiatry Res	2021	1
Hypocretin/Orexin Receptor Pharmacology and Sleep Phases. [PMID:34052813]	Sun Y, Tisdale RK, Kilduff TS	Front Neurol Neurosci	2021	1
Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Seque [PMID:32822576]	Maynard A, McCoach CE, Rotow JK, Harris	Cell	2020	1
The Ca(2+) Sensor SCaBP3/CBL7 Modulates Plasma Membrane H(+)-ATPase Activity and [PMID:30962395]	Yang Y, Wu Y, Ma L, Yang Z, Dong Q, Li Q	Plant Cell	2019	1
Sleep drives metabolite clearance from the adult brain. [PMID:24136970]	Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Th	Science	2013	1
Impact of preinterventional plaque composition and eccentricity on late-acquired [PMID:22936019]	Sato T, Kameyama T, Noto T, Nozawa T, In	Coron Artery Dis	2012	1
Melatonin Promotes the Synthesis and Secretion of Growth Hormone in the Adenohyp [PMID:41870323]	["Zheng Y", "Chen Q", "Guo H", "Zhang Y"	Journal of pineal research	2026	0
Screening natural raw materials and product development for improving insomnia b [PMID:41578474]	["Yue L", "Jiao Q", "Li J", "Lu Y", "Yi	Medicine	2026	0
Pharmacological modulation of MRAP2 protein on murine melatonin receptor signali [PMID:40510472]	Song W, Li Y, Xu H, Zhang Y, Liu L, Li Y	Frontiers in endocrinology	2025	0
Regulation of therapeutic protein release in response to circadian biomarkers. [PMID:41198646]	Franko N, Li S, Galvan S, Csorba Z, Teix	Nature communications	2025	0
Signal transduction, dimerization, and therapeutic targeting of Orexin and recep [PMID:41383480]	Zhang S, Wang P, Ji B, Shao Y, Hou S et	Front Pharmacol	2025	0
Polymorphisms in MTNR1A (rs2119882) and CLOCK (rs1801260) genes are associated w [PMID:40705802]	Chi Y, Yang X, Deng D, Li P, Zhang Y	PloS one	2025	0
Electroconvulsive Therapy Versus Repetitive Transcranial Magnetic Stimulation in [PMID:38456234]	Katarzyna Popiolek; Tor Arnison; Robert	The journal of ECT	2024	0
Bioinformatic analysis of neuropeptide related genes in patients diagnosed with [PMID:39437604]	Yay F, Ayan D	Comput Biol Med	2024	0
Effects of Paradoxical Sleep Deprivation on MCH and Hypocretin Systems. [PMID:39698172]	Agamme ALDA, Tufik S, Torterolo P, D'Alm	Sleep science (Sao Paulo, Braz	2024	0
Finger friction with leather and seam of new and used softballs with and without [PMID:35678234]	["Kinoshita H"]	Sports biomechanics	2024	0
System-Level Strategies to Improve Home Dialysis: Policy Levers and Quality Init [PMID:37678234]	["Watnick S", "Blake P", "Mehrotra R", "	Clinical journal of the Americ	2023	0
Blast Exposure Induces Acute Alterations in Circadian Clock Genes in the Hypotha [PMID:41127649]	Govindarajulu M, Patel MY, Krishnan J, L	Neurotrauma reports	2023	0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning GLYMPHATIC in their description or question text

Circadian Glymphatic Rescue Therapy (Melatonin-focused)

Score: 0.712 · neurodegeneration · 2026-04-02

## Mechanistic Overview Circadian Glymphatic Rescue Therapy (Melatonin-focused) starts from the claim that modulating MT

Loss of AQP4 Polarization Impairs Glymphatic Perivascular Influx, Causing Metabo

Score: 0.690 · neurodegeneration · 2026-04-21

**Molecular Mechanism and Rationale** The aquaporin-4 (AQP4) water channel represents a critical component of the brain

Glymphatic-Cholinergic Tau Clearance Cascade

Score: 0.666 · neuroscience · 2026-04-07

## Mechanistic Overview Glymphatic-Cholinergic Tau Clearance Cascade starts from the claim that modulating MAPT within t

Treat Glymphatic Failure by Coupling AQP4-Targeted Therapy to Sleep/Noradrenergi

Score: 0.630 · neurodegeneration · 2026-04-21

**Molecular Mechanism and Rationale** The glymphatic system represents a critical brain-wide clearance pathway that fac

AQP4 Missorting in Reactive Astrocytes Drives Glymphatic Failure in Chronic Neur

Score: 0.580 · neurodegeneration · 2026-04-21

**Molecular Mechanism and Rationale** The aquaporin-4 (AQP4) water channel represents a critical component of brain hom

Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscilla

Score: 0.564 · Alzheimer's disease · 2026-04-17

## Mechanistic Overview Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via glymph

Ketone-Primed Thalamocortical Enhancement of Glymphatic Tau Clearance

Score: 0.555 · neuroscience · 2026-04-20

## Mechanistic Overview Ketone-Primed Thalamocortical Enhancement of Glymphatic Tau Clearance starts from the claim that

TREM2-GluN2B Circuit: Microglial Control of Thalamocortical Oscillations and Gly

Score: 0.543 · neuroscience · 2026-04-21

## Mechanistic Overview TREM2-GluN2B Circuit: Microglial Control of Thalamocortical Oscillations and Glymphatic Tau Clea

Glymphatic System-Enhanced Antibody Clearance Reversal

Score: 0.537 · neurodegeneration · 2026-04-02

## Mechanistic Overview Glymphatic System-Enhanced Antibody Clearance Reversal starts from the claim that modulating AQP

TREM2-Dependent Microglial Control of Thalamocortical-Glymphatic Tau Clearance

Score: 0.524 · neuroscience · 2026-04-21

## Mechanistic Overview TREM2-Dependent Microglial Control of Thalamocortical-Glymphatic Tau Clearance starts from the c

Restoring AQP4 Astrocyte Polarization Enhances Glymphatic Tau Clearance and Limi

Score: 0.520 · neurodegeneration · 2026-04-22

## Mechanistic Overview Restoring AQP4 Astrocyte Polarization Enhances Glymphatic Tau Clearance and Limits Template-Depe

Targeting AQP4 Sumoylation to Enhance Glymphatic Clearance as Therapeutic Strate

Score: 0.490 · neurodegeneration · 2026-04-21

## Mechanistic Overview Targeting AQP4 Sumoylation to Enhance Glymphatic Clearance as Therapeutic Strategy in Alzheimer'

GluN2B-Mediated Perivascular Pericyte Control of Glymphatic Tau Clearance

Score: 0.485 · neuroscience · 2026-04-21

## Mechanistic Overview GluN2B-Mediated Perivascular Pericyte Control of Glymphatic Tau Clearance starts from the claim